pentosidine has been researched along with Diabetic Retinopathy in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chua, KH; Iqbal, T; Kuppusamy, UR; Ng, ZX | 2 |
| Borsos, AM; M'bemba, J; Peyroux, J; Selam, JL; Slama, G; Sternberg, M; Urios, P | 1 |
| Fokkens, BT; Los, LI; Mulder, DJ; Schalkwijk, CG; Scheijen, JL; Smit, AJ | 1 |
| Al-Zawahary, WM; Mansour, DE; Radwan, AA; Salman, AG; Swelem, AH | 1 |
| Aiello, LP; Asztalos, BF; Cavallerano, JD; Doria, A; Keenan, HA; King, GL; Monnier, VM; Schaefer, EJ; Sell, DR; Strauch, CM; Sun, JK | 1 |
| Nagaoka, T; Sato, E; Takahashi, A; Yokota, H; Yoshida, A | 1 |
| Ben Yahya, S; Bouzidi, H; Hammami, M; Kerkeni, M; Saïdi, A | 1 |
| Ben Yahia, S; Bouzidi, H; Hammami, M; Kerkeni, M; Letaief, A; Saïdi, A | 1 |
| Fujinami, A; Hasegawa, G; Ikeda, T; Imamura, Y; Kinoshita, S; Nakamura, N; Nakano, K; Obayashi, H; Ogata, M; Ohta, M; Watanabe, A; Yamazaki, M; Yoshikawa, T | 1 |
| Hirata, K; Kubo, K | 1 |
| De Rojas Silva, MV; Rodríguez-García, J; Rodríguez-Segade, S; Sánchez-Salorio, M; Tomé, CC | 1 |
| Fukuhara, M; Fukui, M; Hasegawa, G; Ikeda, T; Nakamura, N; Obayashi, H; Ohta, M; Oku, H; Okuno, T; Sugiyama, T | 1 |
| Khosrof, S; Nagaraj, R; Sady, C | 1 |
| Bailie, KE; Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; McCance, DR; Thorpe, SR | 1 |
| Blanco, MC; Camejo, M; Contreras, I; Giansante, E; Gonzalez, F; Lopez, T; Martinez, N; Molina, M; Postalian, S; Reiser, KM; Sanchez, MR; Suarez, N | 1 |
| Arai, K; Chikuda, M; Hashimoto, H; Obara, Y | 1 |
| Kawashima, S; Kurokawa, K; Maeda, K; Miyata, T; Sugiyama, S; Tanaka, H; Ueda, Y; Van Ypersele de Strihou, C | 1 |
| Aotaki-Keen, A; Handa, JT; Hjelmeland, LM; Lutty, GA; Matsunaga, H; Miyata, T; te Koppele, JM; Verzijl, N | 1 |
| Fedele, D; Lapolla, A; Traldi, P | 1 |
| Engerman, RL; Kern, TS | 1 |
| Matsumoto, Y; Ogata, M; Takahashi, M | 1 |
| Fogarty, J; Lapolla, A; Monnier, VM; Odetti, P; Sell, DR | 1 |
| Baynes, JW; Dunn, JA; Dyer, DG; Lyons, TJ; Silvestri, G | 1 |
1 review(s) available for pentosidine and Diabetic Retinopathy
| Article | Year |
|---|---|
AGE in micro- and macroangiopathy.
Topics: Aging; Animals; Arginine; Arteriosclerosis; Cell Adhesion; Collagen; Cross-Linking Reagents; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Interferon-gamma; Lysine; Membrane Proteins; Microcirculation; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; T-Lymphocytes; Vascular Diseases | 2001 |
3 trial(s) available for pentosidine and Diabetic Retinopathy
| Article | Year |
|---|---|
Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Arginine; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glutathione Peroxidase; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Risk Factors; Superoxide Dismutase | 2013 |
Effects of aspirin or basic amino acids on collagen cross-links and complications in NIDDM.
Topics: Analysis of Variance; Arginine; Aspirin; Biopsy; Blood Glucose; Collagen; Cross-Linking Reagents; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Double-Blind Method; Glycated Hemoglobin; Lysine; Placebos; Skin | 1997 |
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Analysis of Variance; Arginine; Biomarkers; Chromatography, High Pressure Liquid; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Sensitivity and Specificity; Severity of Illness Index | 1998 |
20 other study(ies) available for pentosidine and Diabetic Retinopathy
| Article | Year |
|---|---|
Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
Topics: Adult; Advanced Oxidation Protein Products; Aged; Arginine; Biomarkers; Chemokine CCL2; Diabetic Retinopathy; Female; Genotype; Glutathione Peroxidase; Glycation End Products, Advanced; Humans; Inflammation; Lysine; Male; Middle Aged; NF-kappa B; Polymorphism, Genetic; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Superoxide Dismutase | 2013 |
Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Biopsy; Case-Control Studies; Collagen; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Female; Fluorescence; Humans; Longitudinal Studies; Lysine; Male; Middle Aged; Skin; Spectrometry, Fluorescence | 2016 |
Vitreous advanced glycation endproducts and α-dicarbonyls in retinal detachment patients with type 2 diabetes mellitus and non-diabetic controls.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Case-Control Studies; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Retinal Detachment | 2017 |
Pentosidine - a new biochemical marker in diabetic retinopathy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; Blood Proteins; Case-Control Studies; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2009 |
Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.
Topics: Aged; Arginine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Middle Aged | 2011 |
Correlation between plasma pentosidine concentrations and retinal hemodynamics in patients with type 2 diabetes.
Topics: Arginine; Blood Flow Velocity; Blood Glucose; Body Constitution; Cholesterol; Cross-Linking Reagents; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Hemodynamics; Humans; Laser-Doppler Flowmetry; Lysine; Male; Middle Aged; Prospective Studies; Retinal Artery | 2012 |
Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy.
Topics: Aged; Arginine; Biomarkers; Case-Control Studies; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Tunisia | 2012 |
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Topics: Aged; Arginine; Biomarkers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycation End Products, Advanced; Humans; Hyperlipidemias; Hypertension; Lysine; Male; Microvessels; Middle Aged; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Severity of Illness Index; Up-Regulation | 2013 |
Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy.
Topics: Adult; Aged; Arginine; Cohort Studies; Cross-Linking Reagents; Diabetic Retinopathy; Female; Glycation End Products, Advanced; Humans; Interleukin-6; Lysine; Male; Middle Aged; Retina; Vitreous Body | 2003 |
Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes.
Topics: Arginine; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged | 2004 |
Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Topics: Arginine; Biomarkers; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Glycation End Products, Advanced; Glycosylation; Humans; In Vitro Techniques; Lysine; Middle Aged; Retinal Detachment; Severity of Illness Index; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2005 |
Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Arginine; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Evaluation, Preclinical; Electroretinography; Gene Expression Regulation; Glycation End Products, Advanced; Lysine; Male; Rats; Rats, Sprague-Dawley; Retina; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles; Vascular Endothelial Growth Factor A | 2007 |
Advanced Maillard reaction and crosslinking of corneal collagen in diabetes.
Topics: Antioxidants; Arginine; Collagen; Cornea; Cross-Linking Reagents; Diabetes Mellitus; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Hydroxyproline; Lysine; Maillard Reaction; Pepsin A; Pyridines | 1995 |
Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Collagen; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Maillard Reaction; Male; Microcirculation; Middle Aged; Skin | 1993 |
[Relationship between vascular endothelial growth factors and advanced glycation end products in the human vitreous].
Topics: Adult; Arginine; Cytokines; Diabetic Retinopathy; Disease Progression; Endothelial Growth Factors; Glycation End Products, Advanced; Humans; Lymphokines; Lysine; Middle Aged; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitreous Body | 1998 |
Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine; Bruch Membrane; Choroid; Chromatography, High Pressure Liquid; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Immunoenzyme Techniques; Infant; Lysine; Middle Aged; Pigment Epithelium of Eye; Retinal Drusen | 1999 |
Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.
Topics: Albumins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arginine; Aspirin; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dogs; Glycated Hemoglobin; Glycation End Products, Advanced; Glycosuria; Guanidines; Kidney; Lysine; Neural Conduction; Platelet Aggregation; Random Allocation; Retinal Vessels; Ulnar Nerve | 2001 |
[Relationship between glycoxidation and cytokines in the vitreous of eyes with diabetic retinopathy].
Topics: Arginine; Cytokines; Diabetic Retinopathy; Glycation End Products, Advanced; Humans; Hydrogen Peroxide; Lysine; Vitreous Body | 2001 |
Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Topics: Adult; Arginine; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Female; Humans; Lysine; Male; Models, Biological; Reference Values; Skin; Skin Aging | 1992 |
Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts.
Topics: Aged; Arginine; Cataract; Cataract Extraction; Crystallins; Diabetic Retinopathy; Female; Glycosylation; Humans; Lysine; Male | 1991 |